Investment
Features
FeesSafety
Academy
More
Pluang+

Uniqure shares drop after gene therapy shows weaker results at 4 years for Huntington's disease

Company Fundamentals
29 Sep 2026
Investors Business Daily
View Source
Bearish
Uniqure shares drop after gene therapy shows weaker results at 4 years for Huntington's disease

Uniqure's stock fell sharply after its experimental gene therapy for Huntington's disease showed reduced effectiveness at four years. Initial three-year data indicated an 80% slowdown in disease progression, but this benefit dropped to 44% after four years and was not statistically significant. Despite the disappointing update, analysts remain optimistic that the data could still support regulatory approval. The stock reaction reflects investor concerns over the therapy's long-term impact.

Uniqure's gene therapy update comes as Pluang's Health sector shows mixed activity. For readers following health stocks, here is Pluang's market snapshot as of Sep 29, 2026 19:14 WIB: out of 100 priced US health stocks, 50 rose and 41 fell. Notable movers include Sana Biotechnology Inc (SANA) at USD 2.99 with a 1-day change of +2.05% and a typical hold time on Pluang of 22 days, Adaptive Biotechnologies Corp (ADPT) at USD 29.06 with a 1-day change of +1.93% and 100% buy order activity, and Cytokinetics Inc (CYTK) at USD 67.24 with a 1-day change of +1.63%.

More News

10x Genomics launches Sentira Spatial Analysis, cutting spatial data processing from hours to minutes with NVIDIA GPUs.

10x Genomics launches Sentira Spatial Analysis, cutting spatial data processing from hours to minutes with NVIDIA GPUs.

10x Genomics introduced Sentira Spatial Analysis, a new cloud platform that accelerates spatial biology data processing from hours to minutes using NVIDIA GPU acceleration. This innovation integrates data generation and analysis into one ecosystem, e...

Market News
Bullish
4 hours ago
September often weak for S&P 500, but Q4 outcomes vary; long-term investors advised to stay steady.

September often weak for S&P 500, but Q4 outcomes vary; long-term investors advised to stay steady.

September has a reputation as a weak month for the S&P 500, but data from 2000 to 2025 shows it only fell about one-third of the time, with sharp drops in a few key years. The fourth quarter following a weak September has had mixed results, with some...

Market News
Neutral
4 hours ago
Salesforce seen as cheapest way to own AI software with 49% upside to $348 price target

Salesforce seen as cheapest way to own AI software with 49% upside to $348 price target

Salesforce trades at a lower valuation than Microsoft and ServiceNow despite strong AI revenue growth, with a 24/7 Wall St. price target of $348.23 implying nearly 49% upside from its current price. The company reported solid Q2 FY27 earnings, beatin...

Analyst Insights
Bullish
4 hours ago
Sandisk sees explosive growth with AI demand, trades at 8X earnings despite 620% rally YTD.

Sandisk sees explosive growth with AI demand, trades at 8X earnings despite 620% rally YTD.

Sandisk Corporation is experiencing rapid growth driven by strong demand for AI infrastructure memory chips, projecting Q1 2027 revenue between $10.3 and $10.8 billion and EPS over $46. Despite a 620% rally year-to-date, the stock trades at a modest ...

Market News
Bullish
4 hours ago
Chili's launches Suburban Collection merch celebrating its iconic casual dining culture.

Chili's launches Suburban Collection merch celebrating its iconic casual dining culture.

Chili's Grill & Bar has introduced the Suburban Collection, a new merchandise line inspired by its long-standing role in suburban culture. The collection features comfortable, casual apparel like rugby shirts, hoodies, and tees, along with unique acc...

Others
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App